PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
FLGT vs. SMG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

FLGT vs. SMG

Last updated May 12, 2025

Compare and contrast key facts about Fulgent Genetics, Inc. (FLGT) and The Scotts Miracle-Gro Company (SMG).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FLGT or SMG.

Correlation

The correlation between FLGT and SMG is 0.80, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

FLGT vs. SMG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fulgent Genetics, Inc. (FLGT) and The Scotts Miracle-Gro Company (SMG). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

FLGT:

66.63%

SMG:

39.93%

Max Drawdown

FLGT:

-5.11%

SMG:

-4.10%

Current Drawdown

FLGT:

0.00%

SMG:

-3.85%

Fundamentals

Market Cap

FLGT:

$599.74M

SMG:

$3.11B

EPS

FLGT:

-$1.33

SMG:

$0.58

PEG Ratio

FLGT:

1.32

SMG:

0.25

PS Ratio

FLGT:

2.05

SMG:

0.90

PB Ratio

FLGT:

0.53

SMG:

18.98

Total Revenue (TTM)

FLGT:

$292.45M

SMG:

$3.45B

Gross Profit (TTM)

FLGT:

$111.47M

SMG:

$961.70M

EBITDA (TTM)

FLGT:

-$47.19M

SMG:

$279.70M

Returns By Period

FLGT

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

SMG

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Risk-Adjusted Performance

FLGT vs. SMG — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
FLGT
The Risk-Adjusted Performance Rank of FLGT is 4242
Overall Rank
The Sharpe Ratio Rank of FLGT is 4141
Sharpe Ratio Rank
The Sortino Ratio Rank of FLGT is 3939
Sortino Ratio Rank
The Omega Ratio Rank of FLGT is 3939
Omega Ratio Rank
The Calmar Ratio Rank of FLGT is 4646
Calmar Ratio Rank
The Martin Ratio Rank of FLGT is 4545
Martin Ratio Rank
SMG
The Risk-Adjusted Performance Rank of SMG is 3131
Overall Rank
The Sharpe Ratio Rank of SMG is 3030
Sharpe Ratio Rank
The Sortino Ratio Rank of SMG is 2828
Sortino Ratio Rank
The Omega Ratio Rank of SMG is 2828
Omega Ratio Rank
The Calmar Ratio Rank of SMG is 3636
Calmar Ratio Rank
The Martin Ratio Rank of SMG is 3333
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FLGT vs. SMG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fulgent Genetics, Inc. (FLGT) and The Scotts Miracle-Gro Company (SMG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

No data
No data
No data
No data
No data

Loading data...

Dividends

FLGT vs. SMG - Dividend Comparison

FLGT has not paid dividends to shareholders, while SMG's dividend yield for the trailing twelve months is around 4.89%.

TTM20242023202220212020201920182017201620152014
FLGT
Fulgent Genetics, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SMG
The Scotts Miracle-Gro Company		4.89%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

FLGT vs. SMG - Drawdown Comparison

The maximum FLGT drawdown since its inception was -5.11%, which is greater than SMG's maximum drawdown of -4.10%. Use the drawdown chart below to compare losses from any high point for FLGT and SMG. For additional features, visit the drawdowns tool.

Loading data...

Volatility

FLGT vs. SMG - Volatility Comparison

Loading data...

Financials

FLGT vs. SMG - Financials Comparison

This section allows you to compare key financial metrics between Fulgent Genetics, Inc. and The Scotts Miracle-Gro Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.00500.00M1.00B1.50B2.00B20212022202320242025
73.46M
1.42B
(FLGT) Total Revenue
(SMG) Total Revenue
Values in USD except per share items

FLGT vs. SMG - Profitability Comparison

The chart below illustrates the profitability comparison between Fulgent Genetics, Inc. and The Scotts Miracle-Gro Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.
Gross Margin
Operating Margin
Net Margin
Quarterly
Annual
-20.0%0.0%20.0%40.0%60.0%80.0%20212022202320242025
38.6%
38.6%
(FLGT) Gross Margin
(SMG) Gross Margin
FLGT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Fulgent Genetics, Inc. reported a gross profit of 28.35M and revenue of 73.46M. Therefore, the gross margin over that period was 38.6%.

SMG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, The Scotts Miracle-Gro Company reported a gross profit of 547.90M and revenue of 1.42B. Therefore, the gross margin over that period was 38.6%.

FLGT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Fulgent Genetics, Inc. reported an operating income of -11.90M and revenue of 73.46M, resulting in an operating margin of -16.2%.

SMG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, The Scotts Miracle-Gro Company reported an operating income of 344.70M and revenue of 1.42B, resulting in an operating margin of 24.3%.

FLGT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Fulgent Genetics, Inc. reported a net income of -11.53M and revenue of 73.46M, resulting in a net margin of -15.7%.

SMG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, The Scotts Miracle-Gro Company reported a net income of 217.50M and revenue of 1.42B, resulting in a net margin of 15.3%.